Science Explorer Back to mapMap
Discussion
Researcher · Kettering University · United States

Robert D. Sullivan

Robert D. Sullivan publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Colorectal Cancer Treatments and Studies, Hepatocellular Carcinoma Treatment and Prognosis and Head and Neck Cancer Studies.

OpenAlex
World rank
#1,137,519
of 7,710,434 ranked researchers
Rank in United States
#366,785
of 1,627,098
Works
42
Citations
1.2k
Citations per work
28.6
h-index
16
i10-index 20Top 33% in Oncology
Robert D. Sullivan

What does Robert D. Sullivan research?

Robert D. Sullivan's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (5%), Health Professions (5%).

Everything else: 22 works · 52.9% of their workHealth Sciences: 18 works · 42.5% of their workMedicine: 16 works · 37.9% of their workOncology: 6 works · 14.8% of their workPulmonary and Respiratory Medicine: 5 works · 11.1% of their workSurgery: 3 works · 7.4% of their workEpidemiology: 2 works · 4.6% of their workHealth Professions: 2 works · 4.6% of their workGeneral Health Professions: 2 works · 4.6% of their workLife Sciences: 2 works · 4.6% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 4.6% of their workMolecular Biology: 2 works · 4.6% of their workTHEIR WORKRobert D.Sullivan42works
Life Sciences5%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2252.9%
    1. Medicine1637.9%
    2. Health Professions24.6%
    1. Biochemistry, Genetics and Molecular Biology24.6%
  1. 1Oncology15% of their works
  2. 2Pulmonary and Respiratory Medicine11% of their works
  3. 3Surgery7% of their works
  4. 4Epidemiology5% of their works
  5. 5General Health Professions5% of their works
  6. 6Molecular Biology5% of their works

Research topics

Which keywords describe Robert D. Sullivan's research?

The keywords of their largest research topics: Cetuximab, Chemotherapy, Survival, Diagnosis, Management, Squamous Cell Carcinoma, Fluorouracil and KRAS Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Cetuximab92 topics
  2. Chemotherapy92 topics
  3. Survival82 topics
  4. Diagnosis72 topics
  5. Management72 topics
  6. Squamous Cell Carcinoma72 topics
  7. Fluorouracil51 topic
  8. KRAS Mutations51 topic
  9. Hepatocellular Carcinoma41 topic
  10. Human Papillomavirus41 topic
  11. Liver Cancer41 topic
  12. Oropharyngeal Cancer41 topic
  13. Angiosarcoma31 topic
  14. Chemotherapy-Induced Peripheral Neuropathy31 topic
  15. Ear Tumors31 topic
  16. Epithelioid Hemangioendothelioma31 topic
  17. Heparin-Induced Thrombocytopenia31 topic
  18. Taxanes31 topic
  19. Temporal Bone Carcinoma31 topic
  20. Thrombosis31 topic
  21. HIF-121 topic
  22. Warburg Effect21 topic

Where does Robert D. Sullivan work?

Robert D. Sullivan's main affiliation in the publication record is Kettering University, United States.

How many publications and citations does Robert D. Sullivan have?

OpenAlex counts 42 works and 1,200 citations for Robert D. Sullivan, an h-index of 16, ranking #1,137,519 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Robert D. Sullivan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.